| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/CBDD.12898 |
| P698 | PubMed publication ID | 27809417 |
| P50 | author | Parvez Khan | Q53097178 |
| Faizan Ahmad | Q55172764 | ||
| Md Imtaiyaz Hassan | Q56419392 | ||
| Ehtesham Jameel | Q63769298 | ||
| Asimul Islam | Q75841830 | ||
| P2093 | author name string | Jitendra Kumar | |
| Nasimul Hoda | |||
| Mohd Tarique | |||
| Shahzaib Ahamad | |||
| Huma Naz | |||
| Syed Mumtazuddin | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Upregulation of calcium/calmodulin-dependent protein kinase IV improves memory formation and rescues memory loss with aging | Q24318415 | ||
| The protein kinase complement of the human genome | Q24324497 | ||
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| Molecular docking and structure-based drug design strategies | Q26800097 | ||
| The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells | Q28322032 | ||
| Probing the binding sites of antibiotic drugs doxorubicin and N-(trifluoroacetyl) doxorubicin with human and bovine serum albumins | Q28482550 | ||
| Elucidation of the binding mechanism of coumarin derivatives with human serum albumin | Q28533365 | ||
| Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV | Q28972565 | ||
| Targeting cancer with small molecule kinase inhibitors | Q29547395 | ||
| Protein kinases--the major drug targets of the twenty-first century? | Q29615339 | ||
| Structural model of human PSA: a target for prostate cancer therapy | Q30157883 | ||
| Current updates on computer aided protein modeling and designing. | Q30383153 | ||
| Flow cytometry: retrospective, fundamentals and recent instrumentation. | Q30457706 | ||
| Structure-guided design of peptidic ligand for human prostate specific antigen | Q33300063 | ||
| Ca(2+)-dependent gene expression mediated by MEF2 transcription factors. | Q33885290 | ||
| Cutting edge: Calcium/Calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis. | Q35566402 | ||
| A historical overview of protein kinases and their targeted small molecule inhibitors | Q35711076 | ||
| Calcium and calmodulin function in the cell nucleus | Q35756738 | ||
| The camKK2/camKIV relay is an essential regulator of hepatic cancer | Q35889308 | ||
| Calspermin gene transcription is regulated by two cyclic AMP response elements contained in an alternative promoter in the calmodulin kinase IV gene | Q36567294 | ||
| Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression | Q36665572 | ||
| Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages | Q36984742 | ||
| CaMKII inhibitors: from research tools to therapeutic agents | Q38193798 | ||
| Insight into the therapeutic aspects of 'Zeta-Chain Associated Protein Kinase 70 kDa' inhibitors: a review | Q38232520 | ||
| Recently targeted kinases and their inhibitors-the path to clinical trials | Q38239072 | ||
| FDA-approved small-molecule kinase inhibitors. | Q38480289 | ||
| Current Advances in the Identification and Characterization of Putative Drug and Vaccine Targets in the Bacterial Genomes. | Q38572924 | ||
| Calcium/calmodulin-dependent protein kinase IV: A multifunctional enzyme and potential therapeutic target. | Q38698375 | ||
| Structure guided design of potential inhibitors of human calcium-calmodulin dependent protein kinase IV containing pyrimidine scaffold | Q38801868 | ||
| Search of potential inhibitor against New Delhi metallo-beta-lactamase 1 from a series of antibacterial natural compounds | Q40012894 | ||
| Calcium activates serum response factor-dependent transcription by a Ras- and Elk-1-independent mechanism that involves a Ca2+/calmodulin-dependent kinase | Q40016623 | ||
| Tryptophan fluorescence quenching by enzyme inhibitors as a tool for enzyme active site structure investigation: epoxide hydrolase | Q40253896 | ||
| Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition. | Q40324679 | ||
| PKR-inhibitor binds efficiently with human microtubule affinity-regulating kinase 4. | Q40371998 | ||
| Nuclear calcium transport and the role of calcium in apoptosis | Q40569004 | ||
| Differential activation of CREB by Ca2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity | Q41430917 | ||
| Ca2+-dependent regulation in neuronal gene expression | Q41541475 | ||
| CREB and memory | Q41733280 | ||
| Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV. | Q43968740 | ||
| Fluorescence assay for the binding of ribonuclease A to the ribonuclease inhibitor protein | Q44031296 | ||
| Characterization of inhibitor binding sites of mitochondrial complex I using fluorescent inhibitor | Q44542118 | ||
| CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases | Q45137410 | ||
| Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization | Q45182288 | ||
| A synthetic coumarin (4-methyl-7 hydroxy coumarin) has anti-cancer potentials against DMBA-induced skin cancer in mice. | Q46037576 | ||
| Effect of pH on the structure, function, and stability of human calcium/calmodulin-dependent protein kinase IV: combined spectroscopic and MD simulation studies. | Q46216737 | ||
| Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy | Q46540216 | ||
| Drug development: portals of discovery | Q47572709 | ||
| Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in sma | Q50336497 | ||
| Urea-induced denaturation of human calcium/calmodulin-dependent protein kinase IV: a combined spectroscopic and MD simulation studies. | Q50673182 | ||
| Spectroscopic studies on the interaction between silicotungstic acid and bovine serum albumin. | Q51071300 | ||
| ParDOCK: an all atom energy based Monte Carlo docking protocol for protein-ligand complexes. | Q51905195 | ||
| Curcumin specifically binds to the human calcium-calmodulin-dependent protein kinase IV: fluorescence and molecular dynamics simulation studies. | Q54274640 | ||
| Small-molecule kinase inhibitors: an analysis of FDA-approved drugs. | Q55052388 | ||
| Characterization of a Ca2+/Calmodulin-dependent Protein Kinase Cascade | Q56592961 | ||
| P433 | issue | 5 | |
| P921 | main subject | protein design | Q410814 |
| P304 | page(s) | 741-754 | |
| P577 | publication date | 2016-12-02 | |
| P1433 | published in | Chemical Biology and Drug Design | Q15749458 |
| P1476 | title | Design, synthesis, and biological evaluation of pyrimidine derivatives as potential inhibitors of human calcium/calmodulin-dependent protein kinase IV | |
| P478 | volume | 89 |
Search more.